Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast cancer screening

K M Harris1, V G Vogel

  • 1Department of Radiology, University of Pittsburgh School of Medicine, Pennsylvania, USA.

Cancer Metastasis Reviews
|January 20, 1998
PubMed
Summary
This summary is machine-generated.

Screening mammography reduces breast cancer mortality by 30% in women aged 50-69. Its benefit for younger women (40-49) is uncertain due to study limitations and lower mammography sensitivity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Presynaptic Vesicles Supply Membrane for Axonal Bouton Enlargement during Long Term Potentiation.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Presynaptic vesicles supply membrane for axonal bouton enlargement during LTP.

bioRxiv : the preprint server for biology·2025
Same author

Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation.

Clinical and experimental immunology·2017
Same author

Radiographer workforce role expansion to improve patient safety related to nasogastric tube placement for feeding in adults.

Clinical radiology·2017
Same author

The interaction between physical activity and obesity gene variants in association with BMI: Does the obesogenic environment matter?

Health & place·2016
Same author

Influence of SNP*SNP interaction on BMI in European American adolescents: findings from the National Longitudinal Study of Adolescent Health.

Pediatric obesity·2015
Same journal

HER2 assessment in urothelial carcinoma: standardization challenges and the path forward.

Cancer metastasis reviews·2026
Same journal

Resolving translational challenges in cancer biology through yeast experimental evolution.

Cancer metastasis reviews·2026
Same journal

Spheroids and organoids to study long noncoding RNAs in cancer: how they could replace animal models.

Cancer metastasis reviews·2026
Same journal

Strategies and successes of smoking cessation methods in head and neck cancer patients: a systematic review.

Cancer metastasis reviews·2026
Same journal

The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities.

Cancer metastasis reviews·2026
Same journal

Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progress.

Cancer metastasis reviews·2026
See all related articles

Area of Science:

  • Radiology
  • Oncology
  • Public Health

Background:

  • Breast cancer screening has evolved significantly with technological advancements.
  • Federal regulations now mandate quality standards for screening mammography.
  • Mass screening for breast cancer is a widely adopted practice in the United States.

Purpose of the Study:

  • To evaluate the efficacy of screening mammography in reducing breast cancer mortality.
  • To assess the benefits and limitations of mammography screening across different age groups.
  • To address the uncertainty surrounding screening mammography for women aged 40-49.

Main Methods:

  • Analysis of nine prospective, randomized trials on screening mammography efficacy.
  • Review of data on breast cancer incidence rates and screening outcomes.

Related Experiment Videos

  • Evaluation of mammography sensitivity and screening intervals in younger women.
  • Main Results:

    • A 30% reduction in breast cancer mortality observed in women aged 50-69.
    • Uncertainty regarding mortality reduction benefits for women aged 40-49.
    • Lower sensitivity of mammography in younger women and ineffectiveness of intervals longer than 12 months.

    Conclusions:

    • Screening mammography is effective in reducing mortality for older women but its benefit for younger women remains unclear.
    • Further research is needed to establish optimal screening protocols for women under 50.
    • Despite limitations, mass screening remains a crucial tool for breast cancer mortality reduction in the absence of primary prevention.